EREMX | VEMIX | EREMX / VEMIX | |
Total Expense Ratio | 1.17 | 0.09 | 1,300% |
Annual Report Gross Expense Ratio | 1.34 | 0.09 | 1,489% |
Fund Existence | 11 years | 25 years | - |
Gain YTD | 18.840 | 16.312 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 5000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 191M | 127B | 0% |
Annual Yield % from dividends | 2.93 | 2.76 | 106% |
Returns for 1 year | 17.93 | 17.91 | 100% |
Returns for 3 years | 33.68 | 30.24 | 111% |
Returns for 5 years | 45.73 | 29.97 | 153% |
Returns for 10 years | 54.13 | 68.02 | 80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDOEX | 11.23 | 0.12 | +1.08% |
Morgan Stanley Developing Opportunity I | |||
CEKRX | 15.65 | 0.07 | +0.45% |
Columbia Emerging Markets Inst2 | |||
BDOAX | 11.78 | 0.04 | +0.34% |
iShares MSCI Total Intl Idx Inv A | |||
LMESX | 38.15 | -0.08 | -0.21% |
ClearBridge Appreciation IS | |||
FIMPX | 37.44 | -0.15 | -0.40% |
Nuveen Small Cap Growth Opp I |